陈翊庭最新发声！

Core Viewpoint - The Hong Kong Stock Exchange (HKEX) is experiencing a significant increase in IPO activities and foreign investment interest, reflecting a shift in global asset allocation strategies towards Chinese technology innovation [3][6][7]. Group 1: IPO Market Performance - As of September 2025, the total IPO financing amount in Hong Kong reached HKD 182.9 billion, more than doubling compared to the same period in 2024 [6]. - The strong momentum in the IPO market continues, with nearly 300 public listing applications currently being processed [6]. - The "A+H" listing model has shown remarkable performance, accounting for nearly half of the total IPO financing in the first nine months of the year [9]. Group 2: Secondary Market Activity - The Hong Kong securities market's average daily trading volume reached HKD 256.4 billion by the end of September, a year-on-year increase of 126% [11]. - The derivatives market also saw an increase, with an average daily contract volume of 1.68 million, up 11% year-on-year [11]. Group 3: Interconnectivity and Market Innovations - The interconnectivity mechanisms have been continuously optimized, with significant growth in ETF trading; as of September, the average daily trading volume for southbound ETFs was HKD 4.2 billion [13]. - The average daily trading volume for northbound ETFs reached RMB 3.2 billion [13]. - HKEX plans to launch the Hang Seng Biotechnology Index futures to meet the growing demand for risk management tools in the biotechnology sector [13][14]. Group 4: Future Outlook and Strategic Initiatives - HKEX aims to deepen collaboration with various parties to continuously optimize listing arrangements and expand interconnectivity mechanisms [14]. - The exchange is focused on building a competitive ecosystem for offshore RMB products, enhancing asset allocation and risk hedging tools for both domestic and international investors [14].